regulatory updates 2026

Pharmacy reimbursement in the United States is still governed by legacy payment structures shaped decades ago, long before specialty drugs, […]

The 2025–2026 reimbursement landscape is defined by accelerated regulatory change, driven by cost containment, digital care expansion, and outcome-based payment